Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer

Urology - United States
doi 10.1016/j.urology.2016.10.064
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV

Related search

Efficient Delivery of Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Cancer
Cancer ResearchOncology
2011English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology

Cancer
Cancer ResearchOncology
2017English

Pd15-09 Neoadjuvant vs Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Propensity Matched Analysis

Journal of Urology
Urology
2018English

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Amplification of 7p12 Is Associated With Pathologic Non-Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2020English

Identification of S100a8-Correlated Genes for Prediction of Disease Progression in Non-Muscle Invasive Bladder Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer: Closing the Gap Between Evidence and Practice

Canadian Urological Association Journal
Urology
2016English

Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy